This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
CARD Trial
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Advanced Bladder Cancer
JAVELIN Bladder 100 Trial
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
Urologic Oncology
Prostate Cancer
nmCRPC
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AUA 2022
ASCO 2022
Upcoming
EAU 2022
See All
See All Conference Coverage
PCF
UroToday Home
Video Lectures
nmCRPC Videos
Depression, Bone Health and Exercise in Prostate Cancer - Fred Saad, Tomasz Beer & Charles Ryan
June 27, 2022
Details
Mental Health and Impact on Patients with GU Malignancies - Zachary Klaassen
June 14, 2022
Details
Combination Therapy Associated with Significantly Higher Rates of MFS Compared with ADT Alone Among Men with High-Risk Nonmetastatic Prostate Cancer: STAMPEDE Platform Protocol, Journal Club- Christopher Wallis & Zachary Klaassen
May 24, 2022
Details
The Impact of Imaging and Therapeutics Advances in Nonmetastatic Castration-Resistant Prostate Cancer - David Penson
April 7, 2022
Details
Time Course Profile of Adverse Events With Darolutamide in the ARAMIS Trial – Christian Gratzke
October 27, 2021
Details
Cognitive Assessment in Men with Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Randomly Receiving Darolutamide or Enzalutamide in the ODENZA Trial - Karim Fizazi
October 16, 2021
Details
Delayed Deterioration in Patient Quality of Life, the Impact of Darolutamide on Local Symptoms in the ARAMIS Trial – Neal Shore
September 22, 2021
Details
STAMPEDE Analysis of Abiraterone With or Without Enzalutamide Added to Androgen Deprivation Therapy Compared to ADT Alone In High-Risk Non-Metastatic Prostate Cancer Patients– Gerhardt Attard
September 20, 2021
Details
Overall Survival Data from the Global, Phase 3 ARAMIS Trial in Men with Non Metastatic Castration-Resistant Prostate Cancer (nmCRPC) - Karim Fizazi
November 10, 2020
Details
Predictors of Survival, Healthcare Resource Utilization, and Healthcare Costs in Veterans with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) - Stephen Freedland
October 6, 2020
Details
Significantly Longer Metastasis-Free Survival and Overall Survival in the ARAMIS Trial, Nonmetastatic Castration-Resistant Prostate Cancer - Christopher Wallis & Zachary Klaassen
September 30, 2020
Details
ARAMIS Trial Demonstrates Significant Improvement in Overall Survival in nmCRPC - Neal Shore
June 29, 2020
Details
The PROSPER Trial: Enzalutamide Demonstrates Significant Improvement in Overall Survival in Nonmetastatic Castration-Resistant Prostate Cancer - Cora Sternberg
June 15, 2020
Details
Overall Survival Results of Phase III ARAMIS Study of Darolutamide Added to ADT for Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) - Karim Fizazi
June 9, 2020
Details
ARAMIS Trial: Darolutamide Demonstrates Improved Overall Survival in Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) - Fred Saad
May 28, 2020
Details
Treatment Advances in Non-Metastatic Castration-Resistant Prostate Cancer - Evan Yu
May 18, 2020
Details
Prolonging Overall Survival in Men with Non-metastatic Castration Resistant Prostate Cancer ARAMIS Trial - Neal Shore
April 13, 2020
Details
Benefits of Early AR Targeting in Metastatic Hormone Sensitive Disease and nmCRPC - Karim Fizazi
April 3, 2019
Details
Considerations for the Treatment of Non Metastatic Castration-Resistant Prostate Cancer - An Interview with Maha Hussain and Tia Higano
February 4, 2020
Details
Systemic Therapies for Node-Positive Non-Metastatic Castration Resistant Prostate Cancer - Nicholas James
October 31, 2019
Details
Long-term Follow-up of Non-metastatic (M0) Patients in the STAMPEDE Randomized Trial - Interview with Nicholas James
October 9, 2019
Details
Optimal Treatment of Newly Diagnosed Metastatic Prostate Cancer Presentation - Noel Clarke
October 3, 2019
Details
The Definition and Overview of Treatment Options in nmCRPC Presentation - Howard Scher
September 25, 2019
Details
The Treatment of Non-Metastatic Castration-Resistant Prostate Cancer: "Pros" Presentation - Maha Hussain
September 24, 2019
Details
The "Cons" of Treating nmCRPC - Important Considerations to Take into Account Presentation - Celestia Higano
September 24, 2019
Details
Darolutamide Treated Patients Maintained Quality of Life in ARAMIS Trial - Fred Saad
August 4, 2019
Details
ARAMIS Trial in Prostate Cancer: Impact of Darolutamide on Pain and Quality of Life - Karim Fizazi
June 5, 2019
Details
Darolutamide Demonstrates Efficacy and Safety in Men with nmCRPC - Neeraj Agarwal
February 26, 2019
Details
ARAMIS - Efficacy and Safety of Darolutamide in nmCRPC - Karim Fizazi
February 21, 2019
Details
Delaying Disease Progression in Early Nonmetastatic CRPC Treatment - Fred Saad
February 21, 2019
Details
Abiraterone Acetate for nmCRPC, The Forgotten Dance Partner? - Zach Klaassen and Chris Wallis
December 12, 2018
Details
IMAAGEN Trial: A Look into the Non-Metastatic Prostate Cancer Space - Charles Ryan
November 6, 2018
Details
Comparison Between Surgery and Radiotherapy in the Treatment of Non-Metastatic Prostate Cancer- Christopher Wallis
November 2, 2018
Details
Phase III ARAMIS Trial Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint - Tom Keane
October 24, 2018
Details
Combination Therapies and Quality of Life Data in Prostate Cancer - Fred Saad
October 11, 2018
Details
nmCRPC Patient Population - Discussion with Charles Ryan and Alicia Morgans
October 8, 2018
Details
The PROSPER Trial: Chemotherapy-Related Endpoints in Patients with nmCRPC - Neal Shore
August 14, 2018
Details
AUA Castration-Resistant Prostate Cancer Guidelines - Interview with Michael Cookson
May 20, 2018
Details
The Incredible Shrinking nmCRPC - Phillip Koo
May 14, 2018
Details
The Implications of the SPARTAN Trial in the treatment of nmCRPC in Clinical Practice - Conversation with Eric Small
April 28, 2018
Details
First presentation of SPARTAN - a phase 3 double-blind, randomized study of apalutamide (APA) versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) - Eric Small
April 18, 2018
Details
nmCRPC Outcomes in the Use of New Androgen Receptor Targeted Therapies - A Conversation with Charles Ryan and Alicia Morgans
April 3, 2018
Details
nmCRPC - Early Treatment Leading to Favorable Outcomes - Fred Saad.
March 22, 2018
Details
Meeting an Unmet Need in the Nonmetastatic Castration Resistant Prostate Cancer Patient Population - Maha Hussain
March 19, 2018
Details
Changing the Landscape of nmCRPC - The SPARTAN Trial - Eric Small
March 6, 2018
Details
Discussion on PROSPER: Safety and Efficacy Study of Enzalutamide in Patients with nmCRPC - Thomas Keane
February 15, 2018
Details
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
